CMAB is a flexible full-service CDMO dedicated to providing bespoke development manufacturing services of antibodies and biologics for clients in China and across the globe. Our adaptable, client oriented strategy treats every client product like our own.
“For biopharmaceutical companies seeking a fresh
CDMO approach, we invite you to get in touch.”
Our expert team, with a proven track record in biologics, founded CMAB to provide customers with an outstanding CDMO partner in China.
As a young company built by an experienced team, CMAB has the dynamism to reinvent the CDMO platform. By prioritizing capacity, experience, cost-efficiency and quality we have asked ourselves, “What if…?”
Strong commercial backing and committed investors have supported the development of CMAB’s Pilot Facility in Suzhou, China. The Facility is designed to provide full-service manufacturing of Drug Substance and Drug Product, including Process and Analytical Development for pre-clinical and clinical stage biologics manufacturing.